Advances in Lung Cancer Treatment Strategies
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 15 March 2026
Special Issue Editors
2. Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy
Interests: cardiothoracic surgery; radio-guided thoracic surgery; mediastinal tumor surgery; tracheal surgery; minimally invasive thoracic surgery; surgery of mesothelioma; lung cancer staging and treatment; video-assisted sympathectomy for essential hyperhidrosis; surgery of bullous emphysema; lung volume reduction surgery; video-assisted thoracic surgery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Lung cancer remains a major global health challenge, with non-small cell lung cancer (NSCLC) accounting for most diagnoses. Despite progress in individual treatments, outcomes—especially in advanced stages—are still poor. Recent therapeutic advances have transformed treatment paradigms by integrating immunotherapy, targeted agents, and conventional approaches like chemotherapy, radiotherapy, and surgery. The identification of targetable molecular alterations and advances in immune checkpoint inhibitors have enabled highly personalized strategies. A deeper understanding of tumor biology and the immune microenvironment has led to the development of combination therapies customized to the specific molecular characteristics of each patient. Assessment of Programmed Death-Ligand 1 (PD-L1) expression and molecular profiling for driver mutations now play key roles in guiding therapeutic decisions. Integrated treatments are being applied not only in advanced stages but also increasingly in early-stage disease, with the aim of improving survival and quality of life. This Special Issue explores current advances in lung cancer treatment, focusing on clinical progress and innovations and highlighting how multidisciplinary strategies can improve outcomes across all stages.
Dr. Alessandro Gonfiotti
Dr. Alice Ravasin
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lung cancer
- immunotherapy
- immune checkpoint inhibitors
- chemoimmunotherapy
- target therapy
- biomarkers
- non-small-cell lung cancer
- precision medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
